You are here: Industry Insights > ICON

News List

Varian and Icon Group Partner to Extend Commitment to Global Cancer Care prnasia
April 28, 2021
Varian, a Siemens Healthineers company, has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden.
Healthcare industry reported 85 deals worth $30 billion in Feb 2021 expresspharma
March 08, 2021
In February 2021, the healthcare industry reported 85 deals worth $30 billion as compared to last 12-month average (February 2020 to January 2021) of 88 deals worth $17.3 billion.
Icon to Acquire PRA Health Sciences contractpharma
March 02, 2021
Icon, a company creating a new paradigm for bringing clinical research to patients, has agreed to acquire PRA Health Sciences Inc. in a cash and stock transaction valued at approximately $12 billion.
ICON to acquire PRA Health Sciences in $12bn deal pharmatimes
March 01, 2021
Dublin-based clinical trials group ICON is set to acquire rival contract research organisation (CRO) PRA Health Sciences in a deal worth approximately $12bn.
BARDA Reselects ICON as Preferred Partner contractpharma
October 30, 2020
ICON plc, a global CRO, has been re-selected by the Biomedical Advanced Research and Development Authority (BARDA) to continue being part of its exclusive Medical Countermeasures Clinical Studies Network (CSN).
ICON Signs New Service Agreement With Pfizer contractpharma
April 14, 2020
ICON plc, a global provider of drug and device development and commercialization services to the pharmaceutical, biotechnology and medical device industries, has signed a three-year agreement with Pfizer.
ICON Launches Coronavirus Observatory contractpharma
March 24, 2020
Provides real-time updates on COVID-19 vaccine trials and insights into key issues.